Staphylococcus epidermidis Bacteria Reduction

Authors
Park Seo-Hyun and Jeon, Yong- Woo, Technical Manager
Facility
Korea Testing Laboratory
Download
Full Report

Defend 1050 Reduces Staphylococcus epidermidis

Objective

To assess the performance of the Defend 1050 in reducing Staphylococcus epidermidis bacteria. Staphylococcus epidermidis bacteria is a surrogate for methicillin-resistant Staphylococcus aureus (MRSA). MRSA is an example of a superbug.

Methodology

  • Test Method: KOUVA AS02: 2019
  • Bacteria: Staphylococcus epidermidis (ATCC 12228)
  • Temperature: (23 +/- 2) °C
  • Humidity: (50 +/- 5) % R.H.
  • Test time: 1 hour
  • Test chamber: 60m3
  • Air flow: Maximum

Summary of Results

The Defend 1050 achieved a 99.9% reduction of Staphylococcus epidermidis bacteria in 60 minutes in a 60m3 chamber.

Contact

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118
info@wellairsolutions.com

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750
info@wellairsolutions.com

Contact WellAir

Social

Partners